Abstract:Reducing inappropriate antibiotic prescribing for acute respiratory infections (ARIs) is crucial for combating antimicrobial resistance. 1 Japan has implemented several outpatient antibiotic stewardship initiatives since 2016, with limited success. 2 To enhance antibiotic stewardship, we examined clinic characteristics associated with antibiotic prescribing for ARIs in primary care in Japan. This cross-sectional study analyzed data from the Japan Medical Data Survey (JAMDAS), an electronic health record database of nationwide primary care clinics in Japan, compiled by M3, Inc. 3 The University of Tokyo Ethics Committee approved this study and waived written informed consent because we used deidentified data. Details of data, measurements, and statistical analysis are provided in the eMethods in Supplement 1. Per the STROBE reporting guideline, we analyzed outpatient visits for nonbacterial ARIs (defined using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes of J00-J06 or J20-J22, excluding visits with codiagnoses for which antibiotics may be appropriate) for adults aged 18 to 99 years in clinics continuously observed in the JAMDAS database from October 1, 2022, to September 30, 2023. To focus on clinics engaged in adult primary care, we excluded clinics whose physician-owners had board certification in otolaryngology or pediatrics and clinics with fewer than 100 nonbacterial ARI visits in the study period. To examine the association of clinic characteristics with overall antibiotic prescribing, we used a multivariable logistic regression model that adjusted for visit characteristics and prefectures. Clinic characteristics included physician-owners' sex and age (<45, 45-59, or ≥60 years), patient volume (clinic-level tertile of median number of daily patients), and group practice indicator (vs solo practice). To make national estimates, we used JAMDAS-provided clinic-level weights. 3 Analyses were repeated with broad-spectrum antibiotic prescriptions (defined as third-generation cephalosporins, macrolides, and fluoroquinolones 1 ) and the other antibiotic prescriptions as separate outcomes. To adjust for multiple comparisons, we used the Holm method and considered adjusted P < .05 as statistically significant. After excluding 21 377 visits in 32 clinics with missing physician-owners' age, we analyzed 977 590 ARI visits from 977 590 patients (mean [SD] age, 49.7 [20.1] years; 56.9% female) in 1183 clinics (Table 1). Antibiotics were prescribed for 171 483 visits (17.5%), with broad-spectrum antibiotics comprising 88.3% of the total antibiotic prescriptions. Clarithromycin was most commonly prescribed (52 662 visits [30.7%]), followed by levofloxacin (20 948 visits [12.2%]), cefditoren (19 260 visits [11.2%]), azithromycin (19 080 visits [11.1%]), cefcapene (15 802 visits [9.2%]), and amoxicillin (13 591 visits [7.9%]). Antibiotics were more likely to be prescribed in clinics owned by older physicians (adjusted odds ratio [AOR] for ≥60 vs <45 years, 2.14; 95% CI, 1.56-2.92; adjusted P < .001) and clinics with higher patient volumes (AOR for high vs low, 1.47; 95% CI, 1.11-1.96; adjusted P = .02) (Table 2). Group practices were less likely to prescribe antibiotics than solo practices (AOR, 0.71; 95% CI, 0.56-0.89; adjusted P = .01). We found no evidence that antibiotic prescription proportions differed by physician-owner's sex. Similar associations were found for broad-spectrum antibiotics but not for the other antibiotics. Broad-spectrum antibiotics comprised most antibiotics for ARIs. Promotion of the appropriate use of broad-spectrum antibiotics is needed. 4 High patient volume clinics may overprescribe antibiotics because of time pressure or decision fatigue. This is important as Japanese physicians see twice as many outpatients as the Organisation for Economic Cooperation and Development, on average. 5 Group practices may reduce antibiotic prescribing because of lower individual workload and more peer discussions. 6 Older physicians may need updated antibiotic use training because of limited prior opportunities. Limitations included relying on administrative diagnosis codes, lack of comparison before and after the pandemic onset, and limited generalizability to clinics outside JAMDAS or to other clinical settings. In this cross-sectional study of nationwide primary care clinics in Japan, higher-volume clinics, solo practices, and clinics owned by older physicians were more likely to prescribe antibiotics, especially broad-spectrum antibiotics, for nonbacterial ARIs. Our findings could help policymakers implement more targeted interventions in ongoing antibiotic stewardship efforts. Accepted for Publication: August 27, 2024. Published: October -Abstract Truncated-

Epidemiology and patterns of empiric antimicrobial therapy practice in patients with community-onset sepsis using data from a Japanese nationwide medical claims database—the Japan Sepsis Alliance (JaSA) study group

A 10 Year Surveillance for Antimicrobial Susceptibility of Escherichia Coli and Klebsiella Pneumoniae in Community- and Hospital-Associated Intra-Abdominal Infections in China

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Epidemiology of sepsis in a Japanese administrative database

Antimicrobial resistance patterns of WHO priority pathogens isolated in hospitalized patients in Japan: A tertiary center observational study

Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals

Study of Empiric Antibiotic Prescription Patterns and Microbiological Isolates in Hemodynamically Stable and Unstable ICU Patients With Community-Acquired Sepsis

Trend in antibiotic prescription at pediatric primary emergency medical centers in Japan: A multi-center, cross-sectional study

Multiple Blood Culture Sampling, Proper Antimicrobial Choice, and Adequate Dose in Definitive Therapy Supported by the Antimicrobial Stewardship Team Could Decrease 30-Day Sepsis Mortality Rates

Impact of pharmacist-driven antimicrobial stewardship interventions in a secondary care facility in Japan: A pragmatic quasi-experimental study

Mortality analysis among sepsis patients in and out of intensive care units using the Japanese nationwide medical claims database: a study by the Japan Sepsis Alliance study group

Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use

Clinic Characteristics and Antibiotic Prescribing for Acute Respiratory Infections in Japan

Empiric antimicrobial therapy in the intensive care unit based on the risk of multidrug-resistant bacterial infection: a single-centre case‒control study of blood culture results in Japan

No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study

Time from admission to the onset of methicillin-resistant Staphylococcus aureus bacteremia in a single acute care hospital in Japan

Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)

Epidemiology and prevention of surgical site infection in Japan

Prevalence of Empiric Antibacterial Therapy, Community-Acquired Bacterial Superinfection, and Antibiotic-Associated Adverse Reactions among Patients with COVID-19 Pneumonia Admitted in Makati Medical Center from March 2020 to March 2021

Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital

Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus